Advertisement
Screener

ENvue Medical, Inc. (FEED) Material Contracts

ENvue Medical, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-12: Form 8-K; Exhibit 10.2; Description Form of Second Amendment Agreement, dated as of August 12, 2026, by and between the Company and the investor signatory thereto..
  • 2026-08-12: Form 8-K; Exhibit 10.1; Description Form of Common Shares Purchase Agreement, dated as of August 12, 2026, by and between the Company and the investor signatory thereto..
  • 2026-02-06: Form 8-K; Exhibit 10.2; Description Chairman Agreement, dated February 2, 2026, by and between the Company and David Johnson..
  • 2026-02-06: Form 8-K; Exhibit 10.1; Description First Amendment, dated February 2, 2026, to the Amended and Restated Employment Agreement dated as of December 17, 2025, by and between the Company and Doron Besser..
FiledFormExhibitDescription
2026-08-128-K10.2Form of Second Amendment Agreement, dated as of August 12, 2026, by and between the Company and the investor signatory thereto.
2026-08-128-K10.1Form of Common Shares Purchase Agreement, dated as of August 12, 2026, by and between the Company and the investor signatory thereto.
2026-02-068-K10.2Chairman Agreement, dated February 2, 2026, by and between the Company and David Johnson.
2026-02-068-K10.1First Amendment, dated February 2, 2026, to the Amended and Restated Employment Agreement dated as of December 17, 2025, by and between the Company and Doron Besser.
2026-01-308-K10.1Form of Amendment Agreement, dated as of January 30, 2026, by and among the Company and the holders party thereto.
2025-12-308-K10.1Amended and Restated 2024 Long Term Incentive Plan of ENvue Medical, Inc., dated as of December 24, 2025
2025-12-238-K10.2Consulting Agreement, dated as of December 18, 2025, by and between the Company and RCM Financial Consulting, Inc.
2025-12-238-K10.1Amended and Restated Employment Agreement, dated as of December 17, 2025, by and between the Company and Doron Besser, M.D.
2025-12-058-K10.1First Amendment to the NanoVibronix, Inc. 2024 Long-Term Incentive Plan.
2025-09-178-K10.1Form of Securities Purchase Agreement, dated September 17, 2025, by and between the Company and the purchaser thereto.
2025-08-148-K10.1Amended and Restated Employment Agreement, dated as of August 11, 2025, by and between NanoVibronix, Inc. and Stephen Brown
2025-07-308-K10.1Employment Agreement, dated as of February 12, 2025, by and between Rita Silberberg and ENvue Medical Israel Ltd.
2025-07-228-K10.1Form of Securities Purchase Agreement, dated July 18, 2025, by and between the Company and the purchaser thereto
2025-05-168-K10.1Form of Amendment Agreement, dated as of May 12, 2025, by and among the Company and the holders party thereto.
2025-04-118-K10.1Guaranty, dated as of April 11, 2025, by and between the Company and Alpha Capital Anstalt
2025-03-3110-K10.78Amended and Restated Senior Convertible Debenture Due the Earlier of the Trigger Date and November 13, 2025
2025-02-148-K10.2Form of Registration Rights Agreement, dated as of February 13, 2025, by and between NanoVibronix, Inc. and the purchaser named therein.
2025-02-148-K10.1Form of Securities Purchase Agreement, dated as of February 13, 2025, by and between NanoVibronix, Inc. and the purchaser named therein.
2025-01-078-K10.1Form of Exchange Agreement
2024-12-208-K10.1NanoVibronix, Inc. 2024 Long-Term Incentive Plan.
2024-09-258-K10.2Employment Agreement, dated as of September 20, 2024, by and between Stephen Brown and NanoVibronix, Inc.
2024-09-258-K10.1Employment Agreement, dated as of September 20, 2024, by and between Brian Murphy and NanoVibronix, Inc.
2024-04-0810-K10.76Research Agreement, dated October 1, 2023, by and between NanoVibronix Inc. and the Regents of the University of Michigan.
2024-04-0810-K10.75Standalone Services Agreement, dated March 22, 2024, by and between NanoVibronix, Inc. and Veranex, Inc.
2023-12-048-K10.9Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Thomas Mika
2023-12-048-K10.8Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Stephen Brown
2023-12-048-K10.7Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Michael Ferguson
2023-12-048-K10.6Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Martin Goldstein
2023-12-048-K10.5Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Maria Schroeder
2023-12-048-K10.4Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Harold Jacob
2023-12-048-K10.3Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Christopher Fashek
2023-12-048-K10.2Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Brian Murphy
2023-12-048-K10.1Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Aurora Cassirer
2023-11-1310-Q10.1Second Amendment to the Amended and Restated Distribution Agreement for “Private-Labled” Products dated December 10, 2020 by and between NanoVibronix, Inc. and Ultra Pain Products Inc.
2023-09-018-K10.2Form of Registration Rights Agreement
2023-09-018-K10.1Form of Securities Purchase Agreement
2022-12-158-K10.1Fourth Amendment to the Nanovibronix, Inc. 2014 Long-Term Incentive Plan
2022-12-018-K10.1Form of Securities Purchase Agreement
2022-05-0210-K/A10.62Employment Agreement, dated January 1, 2022, by and between NanoVibronix, Inc. and Stephen Brown.
2022-05-0210-K/A10.61Employment Agreement, dated January 1, 2022, by and between NanoVibronix, Inc. and Brian Murphy
2021-12-308-K10.1Third Amendment to the Nanovibronix, Inc. 2014 Long-Term Incentive Plan
2021-04-1510-K10.58Amended and Restated Distribution Agreement for “Private Label” Products dated December 10, 2020 by and between NanoVibronix, Inc. and Ultra Pain Products Inc.
2021-01-228-K10.1Form of Letter Agreement
2020-12-078-K10.2Form of Registration Rights Agreement, dated December 2, 2020.
2020-12-078-K10.1Form of Securities Purchase Agreement, dated December 2, 2020.
2020-11-058-K10.6Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Thomas Mika
2020-11-058-K10.5Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Stephen Brown
2020-11-058-K10.4Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Michael Ferguson
2020-11-058-K10.3Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Martin Goldstein
2020-11-058-K10.2Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Christopher Fashek
2020-11-058-K10.1Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Brian Murphy
2020-10-088-K10.1Employment Agreement, dated as of October 5, 2020, between NanoVibronix, Inc. and Stephen Brown
2020-08-1910-Q10.3Note between the Company and Cross River Bank (SBA – Payroll Protection Program loan), dated May 14, 2020.
2020-06-268-K10.2Form of Warrant
2020-06-268-K10.1Form of Note
2019-07-318-K10.2SECURITIES PURCHASE AGREEMENT, DATED AS OF JULY 31, 2019, BY AND AMONG THE COMPANY AND EACH INVESTOR IDENTIFIED ON THE SIGNATURE PAGES THERETO
2019-07-318-K10.1SECURITIES PURCHASE AGREEMENT, DATED AS OF JULY 31, 2019, BY AND AMONG THE COMPANY AND EACH INVESTOR IDENTIFIED ON THE SIGNATURE PAGES THERETO
2019-06-268-K10.1SECURITIES PURCHASE AGREEMENT, DATED AS OF FEBRUARY 18, 2014, BY AND AMONG THE COMPANY AND EACH INVESTOR IDENTIFIED ON THE SIGNATURE PAGES THERETO
2019-06-048-K10.1CFO Consulting Agreement, dated as of June 1, 2019, between NanoVibronix Inc. and James S. Cardwell.
2019-05-2010-Q10.2Convertible Promissory Note issued (AiGH), May
2019-05-2010-Q10.1Convertible Promissory Note (Globis), May 10, 2019
2019-04-1510-K10.39Form of Warrant
2019-04-1510-K10.38Convertible Promissory Note
2019-04-1510-K10.37Convertible Promissory Note
2019-04-1510-K10.36Consulting Agreement dated as of February 21,2019, between Nanovibronix, Inc and Bespoke Growth Partners, Inc.
2018-07-108-K10.1Separation and Release Agreement, dated July 4, 2018, between NanoVibronix, Inc. and Jona Zumeris and Janina Zumeris
2018-06-188-K10.1First Amendment to the NanoVibronix, Inc. 2014 Long-Term Incentive Plan
2017-09-268-K10.3Form of Letter Agreement
2017-09-268-K10.2Form of $5.90 Warrant
2017-09-268-K10.1Form of Note
2017-09-148-K/A10.1Form of Letter Agreement, dated September 7, 2017, between NanoVibronix, Inc. and holders of the 2017 Notes
2017-09-128-K10.1Form of Letter Agreement, dated September 7, 2017, between NanoVibronix, Inc. and holders of the 2017 Notes
2017-08-298-K10.2Form of $5.90 Warrant
2017-08-298-K10.1Form of Note
2017-06-098-K10.2Form of $5.90 Warrant
2017-06-098-K10.1Form of Note
2017-05-058-K10.2Form of $5.90 Warrant
2017-05-058-K10.1Form of Note
2017-03-3110-K10.52First Amendment to Nonqualified Stock Option Agreement, dated March 30, 2017, between NanoVibronix, Inc. and Ira A. Greenstein.
2017-03-3110-K10.51First Amendment to Nonqualified Stock Option Agreement, dated March 30, 2017, between NanoVibronix, Inc. and Ira A. Greenstein.
2017-03-3110-K10.46Form of Amendment to Warrant to Purchase Common Stock, effective as of January 27, 2017.
2017-03-278-K10.2$5.90 Warrant, dated March 23, 2017
2017-03-278-K10.1Convertible Promissory Note, dated March 23, 2017
2017-03-078-K10.2Form of $5.90 Warrant
2017-03-078-K10.1Form of Note
2016-10-198-K10.3Employment Agreement, dated October 13, 2016, between NanoVibronix, Inc. and Brian Murphy
2016-10-198-K10.2Nonqualified Stock Option Agreement, dated October 14, 2016, between NanoVibronix, Inc. and Christopher M. Fashek
2016-10-198-K10.1Offer Letter, dated October 14, 2016, between NanoVibronix, Inc. and Christopher M. Fashek
2015-03-3010-K10.44Form of 102 Award Agreement under the Israeli Appendix to the 2014 Long-Term Incentive Plan
2015-03-3010-K10.43Form of 3(i) Award Agreement under the Israeli Appendix to the 2014 Long-Term Incentive Plan
2015-03-3010-K10.42Form of Restricted Stock Award Agreement under the 2014 Long-Term Incentive Plan
2015-03-3010-K10.41Form of Nonqualified Stock Option Award Agreement under the 2014 Long-Term Incentive Plan
2015-03-3010-K10.40Form of Incentive Stock Option Award Agreement under the 2014 Long-Term Incentive Plan
2015-03-3010-K10.39Letter Agreement, dated March 25, 2015, by and between NanoVibronix, Inc. and Martin Goldstein
2015-03-3010-K10.38Warrant to Purchase Common Stock, dated March 25, 2015
2015-03-3010-K10.37Side Letter to Consulting Agreement, dated March 25, 2015, by and among NanoVibronix, Inc. and AYTA Consulting, LLC
2015-03-3010-K10.36Employment Agreement, dated March 25, 2015, by and between William Stern and NanoVibronix, Inc.
2015-03-3010-K10.35Services Agreement, dated March 25, 2015, by and between Multigon Industries, Inc. and NanoVibronix, Inc.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bone Biologics Corp (BBLG)United States$0.001B
Lifeward Ltd. (LFWD)$0.021B
LogicMark, Inc. (LGMK)United States$0.000B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
ALPHA PRO TECH LTD (APT)$0.052B13.63
Envoy Medical, Inc. (COCH)United States$0.056B
MYOMO, INC. (MYO)United States$0.065B-2.85
Safe Pro Group Inc. (SPAI)United States$0.090B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B